Fundraising Fox
/Companies
Sign in

Concerto

Cambridge, US · Founded 2020 · Delaware corporation · 11 known investors

Find your way into Concerto

Sign up to see every warm intro you have to Concerto

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Concerto team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Concerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition. Its approach combines high-throughput experimental data generation with predictive modeling to make microbial communities engineerable.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

Concerto was founded in 2020 by Jared Kehe, Cheri Ackerman, and Bernardo Cervantes.

JKJared Kehe
Jared KeheCofounder and Chief Scientific OfficerJared Kehe is a co-founder and Executive Officer at Concerto Bio, where he oversees product discovery and technology development. He holds a PhD in Biological Engineering from MIT, where he worked with Prof. Paul Blainey on microfluidics technology applied to microbial ecology, and a BS in Bioengineering from UC San Diego.
CACheri Ackerman
Cheri AckermanCofounder & CEOExecutive Officer, Director at Concertobio
BCBernardo Cervantes
Bernardo CervantesCo-founder · Chief Operating OfficerBernardo Cervantes trained as a microbiologist and microbial engineer with 15 years of experience in molecular biology research focused on microbial engineering for chemical production and human health applications. He is Executive Officer and Director at Concerto Bio, which develops microbe-based consumer health products by generating large-scale ecological datasets on microbial communities.
VSVera Schroeder
Vera SchroederBoard MemberPartner at Safar Partners

Board

SLSarah Luppino
Sarah LuppinoBoard DirectorAssociate at M Ventures

Investors · 11

Excelestar Ventureslisted by Excelestar VenturesAndover

How we know: Excelestar Ventures's portfolio page · Not right? Tell us

Golden Seedslisted by Golden SeedsFlushing · $250K – $2M

How we know: Golden Seeds's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Horizons Ventureslisted by Horizons VenturesHong Kong · $500K – $10M
ISVlisted by ISVWest Palm Beach

How we know: ISV's portfolio page · the VCSheet dataset · Not right? Tell us

M Ventureslisted by M VenturesAmsterdam · $10.8M

How we know: M Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

MassVentureslisted by MassVenturesWaltham · $250K – $500K
Taihill Venturelisted by Taihill VentureCambridge

How we know: Taihill Venture's portfolio page · Not right? Tell us

Axial VCreportedSan Francisco · $100K – $5M

How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

IMPACT SCIENCE VENTURESreportedPalo Alto

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

The Engine VenturesreportedCambridge

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$24.5M disclosed across 1 round · 2022

▶$24.5MraisedJun 2022 · 37 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sarah LuppinoDirector
  • Vera SchroederDirector
  • Jared KeheExecutive Officer, Director
  • Cheri AckermanExecutive Officer, Director
  • Bernardo CervantesExecutive Officer, Director
Offering amount
$24.5M
Amount sold
$24.5M
First sale
Mar 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Concerto went on to found or lead other companies.

Vinit NijhawanInvestor and Board ObserverFounded LearnLaunch +1Robert EthierInvestorFounded Impact Science Ventures

Related companies · 4

bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Actio Biosciences, Inc.Actio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions. It focuses on identifying dysregulated gene activity and designing therapies to restore balance and address the root causes of disease.
Scioto BiosciencesScioto Biosciences is a life sciences company with corporate offices and research facilities in Fishers, Indiana. This page describes its office locations and employee benefits rather than detailing its products.
Ditto BiosciencesDitto Bio uses AI to identify protein candidates from parasites and pathogens for treating autoimmune diseases. The company mines natural compounds from viruses, ticks, and worms whose immune-modulating properties have evolved over millions of years.

Companies working in the same space as Concerto.

Frequently asked questions

What does Concerto do?
Concerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition. Its approach combines high-throughput experimental data generation with predictive modeling to make microbial communities engineerable.
Who founded Concerto?
Concerto was founded by Jared Kehe, Cheri Ackerman, Bernardo Cervantes in 2020.
Who are Concerto's investors?
Concerto's investors include Alumni Ventures, Excelestar Ventures, Golden Seeds, Horizons Ventures, ISV, M Ventures, MassVentures, Taihill Venture and 3 more.
How much funding has Concerto raised?
Concerto has disclosed $24.5M raised across 1 round.
Where is Concerto headquartered?
Concerto is headquartered in Cambridge, US.